20|20 Research Revenue and Competitors

Location

N/A

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • 20|20 Research's estimated annual revenue is currently $23M per year.(i)
  • 20|20 Research's estimated revenue per employee is $112,200

Employee Data

  • 20|20 Research has 205 Employees.(i)

20|20 Research's People

NameTitleEmail/Phone
1
Research ManagerReveal Email/Phone
2
Senior Software EngineerReveal Email/Phone
3
Senior Software Application EngineerReveal Email/Phone
4
Administrative AssistantReveal Email/Phone
5
Senior Global Support SpecialistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$38.3M246-50%$136.4MN/A
#2
$1.6M18-10%N/AN/A
#3
$2.3M23N/AN/AN/A
#4
$4.3M38N/AN/AN/A
#5
$26M23725%$11MN/A
#6
$87.2M498N/AN/AN/A
#7
$4.3M37N/AN/AN/A
#8
$22.7M20742%$6.4MN/A
#9
$0.3M6N/AN/AN/A
#10
$6.1M69-17%$23.5MN/A
#11
$2.1M21N/AN/AN/A
#12
$1.6M23N/AN/AN/A
#13
$0.2M3N/AN/AN/A
#14
$10.9M107-12%$5MN/A
#15
$1185M57156%$115.8MN/A
#16
$5.2M45-29%N/AN/A
#17
$0.3M4N/AN/AN/A
#18
$0.2M3N/AN/AN/A
#19
$3.9M34N/AN/AN/A
#20
$0.5M7N/AN/AN/A
Add Company

What Is 20|20 Research?

keywords:N/A

N/A

Total Funding

205

Number of Employees

$23M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

20|20 Research News

2022-04-20 - Blood Thinner Research Published in Journal

Samaritan research on the use of the blood thinner apixaban in ... In the past 20 years, Joss' researchers have had at least three of their...

2022-04-20 - Update: April AT PENN | University of Pennsylvania Almanac

22 Precarity: PhD Conference on Architectural Research; ... 20 Fulbright/IIE Introduction to English Teaching Assistant; 2 p.m..

2022-04-17 - DNR and MSU celebrate 20 years of lake sturgeon research ...

A white person holding an enormous sturgeon in both hands while standing in the Black River For the past 20 years, the Michigan Department of...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$60.9M20559%$82M
#2
$46.2M20513%N/A
#3
$60.9M2051%N/A
#4
$31.9M20737%N/A
#5
$44.9M208-1%$1M